how much is a vial of retatrutide Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Medicare does not typically pay for medications prescribed solely for weight loss, but certain large employers are beginning to offer coverage for GLP-1 agonists used for weight loss

This new option presents patients with a potentially wallet-friendly and accessible option for members looking to slim down

Why GIP Was Initially Controversial Early studies in people with type 2 diabetes found that their insulin response to GIP was diminished compared to people without diabetes

Medications and diagnostic services not included in membership subscription

Semaglutide is 31 amino acids with fatty acid conjugation

What started with semaglutide quickly expanded to tirzepatide, and now retatrutide is generating attention as the next potential breakthrough in obesity treatment